1. "Center for Hematologic Malignancies"
  2. "GSK Faculty"
  3. "Sergio Giralt"
  4. "Biology of Blood and Marrow Transplantation"
Formats
  1. Meeting Abstract (59)
  2. Journal Article (30)
Groups
  1. Bone Marrow Transplant (89)
  2. Center for Hematologic Malignancies (89)
  3. Department of Medicine (89)
  4. GSK Faculty (89)
  5. Hematologic Malignancies, Division of (89)
  6. Immunology Program Faculty (78)

More Groups

People
  1. Sergio Giralt (89)
  2. Miguel-Angel Perales (74)
  3. Richard O'Reilly (61)
  4. Esperanza Papadopoulos (55)
  5. Ann Jakubowski (52)
  6. Molly Maloy (52)

More People

Years
  1. 2020 (11)
  2. 2019 (13)
  3. 2018 (17)
  4. 2017 (13)
  5. 2016 (8)
  6. 2015 (7)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (89)
Publishers
  1. Elsevier Inc. (89)

Results (89)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Host T-cells contribute to immune reconstitution and improved outcome in recipients of CD34 selected T-cell depleted allografts (TCD HCT) with full hematopoietic cell but persistent mixed T-cell chimerism
    Meeting Abstract

    O'Reilly, R. J.; Koehne, G.; Heller, G.; Boulad, F.; Castro-Malaspina, H.; Giralt, S. A.; Jakubowski, A. A.; Kernan, N. A.; Papadopoulos, E. B.; Perales, M.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Population pharmacokinetic model demonstrates poor outcomes with ATG overexposure in adults undergoing ex vivo CD34-selected allogeneic hematopoietic cell
    Meeting Abstract

    Scordo, M.; Cho, C.; Devlin, S. M.; Maloy, M. A.; Ruiz, J. D.; Bhatt, V.; Smith, M.; Shah, G. L.; O'Reilly, R. J.; Papadopoulos, E. B.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • The impact of individual co-morbidities in myeloablative ex vivo CD34+ selected allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Shouval, R.; Fein, J. A.; Devlin, S. M.; Maloy, M. A.; Castillo Flores, N.; Lin, R. J.; Politikos, I.; Sanchez, M.; Scordo, M.; Shah, G. L.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Don't let the HCT-CI fool you: Similar outcomes with myeloablative CD34+ selected allo-HCT compared to unmodified RIC allo-HCT in patients with AML or MDS and high comorbidity scores
    Meeting Abstract

    Pennisi, M.; Cho, C.; Devlin, S. M.; Ruiz, J. D.; Maloy, M. A.; Tomas, A. A.; Castillo, N.; Lin, R. J.; Politikos, I.; Sanchez-Escamilla, M.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Prospective identification of unrelated donors with low inhibitory donor KIR3DL1- Recipient HLA-B interaction decreases relapse and improves survival after allogeneic hematopoietic cell transplantation for myeloid neoplasia
    Meeting Abstract

    Shaffer, B. C.; Park, S.; Le Luduec, J. B.; Devlin, S. M.; Jakubowski, A. A.; Gyurkocza, B.; Papadopoulos, E. B.; Tamari, R.; Giralt, S. A.; Hsu, K. C.
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Durable remission following "off-the-shelf" chimeric antigen receptor (CAR) T-cells in patients with relapse/refractory (R/R) B-cell malignancies
    Meeting Abstract

    Curran, K. J.; Sauter, C. S.; Kernan, N. A.; Prockop, S. E.; Boulad, F.; Perales, M.; Giralt, S. A.; Riviere, I.; Wang, X.; Boelens, J. J.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Comparing car T cells toxicities grading systems: Application of ASTCT grading system and implications for management
    Meeting Abstract

    Pennisi, M.; Jain, T.; Mead, E.; Santomasso, B.; Silverberg, M. L.; Batlevi, Y.; Shouval, R.; Devlin, S. M.; Batlevi, C. W.; Brentjens, R.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Outcomes of two chemotherapy-based preparatory regimens compared to tbi-based conditioning when used with CD34(+) selected T-cell depleted alloHCT for high risk hematologic malignancies: Prospective clinical trial NCT 01119066
    Meeting Abstract

    O'Reilly, R. J.; Koehne, G.; Boulad, F.; Heller, G.; Klein, E.; Barker, J. N.; Castro-Malaspina, H.; Curran, K. J.; Hsu, K. C.; Jakubowski, A. A.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Addition of tocilizumab to cyclosporine-a/ mycophenolate mofetil (CSA/MMF) graft-vs-host disease (GVHD) prophylaxis significantly abrogates pre-engraftment syndrome (PES) & severe acute GVHD after adult double unit cord blood transplantation (dCBT)
    Meeting Abstract

    Politikos, I.; Maloy, M. A.; Devlin, S. M.; Naputo, K.; Bhatt, V.; Skinner, K.; Cho, C.; Dahi, P. B.; Giralt, S. A.; Gyurkocza, B.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Ex vivo T cell-depleted hematopoietic stem cell transplantation for adult patients with acute myelogenous leukemia in first and second remission: Long-term disease-free survival with a significantly reduced risk of graft-versus-host disease
    Journal Article

    Montoro, J.; Ceberio, I.; Hilden, P.; Maloy, M. A.; Barker, J.; Castro-Malaspina, H.; Dahi, P.; Koehne, G.; Perales, M. A.; Ponce, D.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save